Ampicillin resistant texturizing lactic acid bacteria strains

US11484040B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11484040-B2
Application numberUS-201916429468-A
CountryUS
Kind codeB2
Filing dateJun 3, 2019
Priority dateApr 23, 2012
Publication dateNov 1, 2022
Grant dateNov 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to mutants of lactic acid bacteria which are resistant to the antibiotic ampicillin and which were found to give an increased texture when grown in milk while maintaining the other growth properties of the parent strain. The present invention, furthermore, relates to compositions comprising such mutants, and to dairy products fermented with the lactic acid bacteria resistant to ampicillin.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for obtaining a mutant texturizing lactic acid bacteria strain, comprising: (a) selecting and isolating, from a pool of lactic acid bacteria strains obtained from a mother strain without genetic engineering, a pool of mutant lactic acid bacteria strains which are resistant to the antibiotic ampicillin as determined by the amount of ampicillin that reduces the OD 600 measured growth of the lactic acid bacteria strain, after 20 hours growth at 37° C. in a medium suitable for growth of the lactic acid bacteria strain, by 20% as compared to the OD 600 measured growth in the medium without ampicillin being higher than 400 ng/ml; and (b) selecting and isolating from the pool of mutant lactic acid bacteria strains which are resistant to ampicillin a mutant lactic acid bacteria strain that exhibits a texturing property such that the efflux time of 28 ml of full fat cow milk containing 2% (w/v) skimmed milk powder, inoculated with at least 10 4 CFU/ml of the lactic acid bacteria strain and acidified at 37° C. for 20 hours, from a polystyrene 25-ml pipette is at least 50 seconds. 2. A method according to claim 1 , wherein the lactic acid bacteria strain is a strain of Lactobacillus delbrueckii subsp. bulgaricus. 3. A method according to claim 1 , wherein the lactic acid bacteria strain is a strain of Streptococcus thermophiles. 4. A method according to claim 1 , wherein the mother strain is Lactobacillus delbrueckii subsp. bulgaricus strain CHCC13995 that was deposited with the Deutsche Sammlung von Mikroorganismen and Zellkulturen, Braunschweig, Germany (DSMZ) under accession number DSM 24021. 5. A method according to claim 1 , wherein the pool of mutant lactic acid bacteria strains obtained from the mother strain exhibit a Minimum Inhibitory Concentration (MIC) that is at least 1 increment higher in an E-test than that of the mother strain. 6. A method according to claim 1 , wherein the mutant lactic acid bacteria strain exhibits a texturing property such that the efflux time of 28 ml of full fat cow milk containing 2% (w/v) skimmed milk powder, inoculated with at least 10 4 CFU/ml of the lactic acid bacteria strain and acidified at 37° C. for 20 hours, from a polystyrene 25-ml pipette is at double the efflux time of the mother strain. 7. A method according to claim 1 , wherein the mother strain is Lactobacillus delbrueckii subsp. bulgaricus strain CHCC15466 deposited with the DSMZ under accession number DSM 25852. 8. A method according to claim 7 , wherein the mutant strain is a mutant or variant of Lactobacillus delbrueckii subsp. bulgaricus strain CHCC15466 deposited with the DSMZ under accession number DSM 25852.

Assignees

Inventors

Classifications

  • A23C9/1238Primary

    using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

  • Lactobacillus · CPC title

  • Bacterial isolates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11484040B2 cover?
The present invention relates to mutants of lactic acid bacteria which are resistant to the antibiotic ampicillin and which were found to give an increased texture when grown in milk while maintaining the other growth properties of the parent strain. The present invention, furthermore, relates to compositions comprising such mutants, and to dairy products fermented with the lactic acid bacteria…
Who is the assignee on this patent?
Chr Hansen As
What technology area does this patent fall under?
Primary CPC classification A23C9/1238. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).